Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH)-deficient (KO) mice provide a unique system to define the role of CRH in regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Despite several manifestations of chronic glucocorticoid insufficiency, basal pituitary proopiomelanocortin (POMC) mRNA, adrenocorticotrophic hormone (ACTH) peptide content within the pituitary, and plasma ACTH concentrations are not elevated in CRH KO mice. The normal POMC mRNA content in KO mice is dependent upon residual glucocorticoid secretion, as it increases in both KO and WT mice after adrenalectomy; this increase is reversed by glucocorticoid, but not aldosterone, replacement. However, the normal plasma levels of ACTH in CRH KO mice are not dependent upon residual glucocorticoid secretion, because, after adrenalectomy, these levels do not undergo the normal increase seen in KO mice despite the increase in POMC mRNA content. Administration of CRH restores ACTH secretion to its expected high level in adrenalectomized CRH KO mice. Thus, in adrenal insufficiency, loss of glucocorticoid feedback by itself can increase POMC gene expression in the pituitary; but CRH action is essential for this to result in increased secretion of ACTH. This may explain why, after withdrawal of chronic glucocorticoid treatment, reactivation of CRH secretion is a necessary prerequisite for recovery from suppression of the HPA axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CRH is required for posttranscriptional events necessary for the release of ACTH and for trophic support of the adrenal glands [59].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Moved to clinical practice, this model helps to understand that, in adrenal insufficiency, loss of GC feedback, by itself, can increase POMC gene expression in the pituitary (suggesting that CRH is not absolutely required for changes in POMC expression in response to absolute GC deficiency), but CRH action is essential to guarantee the increase of ACTH secretion.”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Adrenalectomy in CRH KO mice determines a further increase in hypothalamic AVP mRNA, demonstrating their ability to respond to the absolute GC deficiency in a manner similar to that of wild-type mice [59].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“In CRH KO mice different expression in AVP and POMC gene between adrenalectomized and intact animals has been observed [59].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [59]
In the citing paper
“If adrenalectomy is performed, POMC mRNA content rises and this increase is reversed by GC replacement, but not by aldosterone.”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [59]
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Feast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow
Dallman, M. F., Strack, A. M., Akana, S. F., Bradbury, M. J., Hanson, E. S., Scribner, K. A., & Smith, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1010 · Cited by 796 · cited 1×
“Depletion of white fat stores also occurs with glucocorticoid insufficiency (29), and, consistent with this, CRH KO males had significantly reduced white fat as compared with WT males (Figure 1b).”
BackgroundGold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Regulation of ACTH Secretion: Variations on a Theme of B
DALLMAN, M. F., AKANA, S. F., CASCIO, C. S., DARLINGTON, D. N., JACOBSON, L., & LEVIN, N. (1987) · Proceedings of the 1986 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571143-2.50010-1 · Cited by 655
Self-citationVasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636 · cited 2×
“In contrast to previous in vivo and in vitro studies (16, 17), this suggested that CRH may not be essential for POMC gene transcription, but may be critical for augmented release of ACTH from the pituitary in response to stress, circadian stimuli, and recovery of the HPA axis after the withdrawal of chronic glucocorti…”
Result
Cited by
Hypothalamic-pituitary-adrenocortical axis regulation
Jacobson, L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.003 · Cited by 248
“Adrenalectomy-induced increases in ACTH are also lacking in the CRH knockout mouse [25].”
BackgroundSelf-citationLund, T. D., Hinds, L. R., & Handa, R. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3777-05.2006 · Cited by 236
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“Adrenalectomy in CRH KO mice determines a further increase in hypothalamic AVP mRNA, demonstrating their ability to respond to the absolute GC deficiency in a manner similar to that of wild-type mice [59].”
BackgroundResultInfluentialBelgardt, B., Husch, A., Rother, E., Ernst, M. B., Wunderlich, F. T., Hampel, B., Klöckener, T., Alessi, D. R., Kloppenburg, P., & Brüning, J. C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.01.006 · Cited by 173
T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation
Brewer, J. A., Khor, B., Vogt, S. K., Muglia, L. M., Fujiwara, H., Haegele, K. E., Sleckman, B. P., & Muglia, L. J. (2003) · Nature Medicine · doi:10.1038/nm895 · Cited by 158
“Mice were adrenalectomized and allowed to recover 1 week before being subjected to experimentation as previously describe”
Self-citationThymocyte Apoptosis Induced by T Cell Activation Is Mediated by Glucocorticoids In Vivo
Brewer, J. A., Kanagawa, O., Sleckman, B. P., & Muglia, L. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1837 · Cited by 132
“Second, corticotropin releasing hormone-deficient animals that lack circadian glucocorticoid surges have a 50% increase in thymus size (23).”
BackgroundSelf-citationCorticotropin-releasing hormone and animal models of anxiety: gene–environment interactions
Bakshi, V. P., & Kalin, N. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01082-9 · Cited by 139
“It is possible that this relative sparing of HPA axis function is related to increases in PVN arginine vasopressin (AVP) mRNA that are seen in CRH knockout mice (Muglia et al 2000).”
Venihaki, M., Sakihara, S., Subramanian, S., Dikkes, P., Weninger, S. C., Liapakis, G., Graf, T., & Majzoub, J. A. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01170.x · Cited by 115
Self-citationGenetic approaches to hypothalamic-pituitary-adrenal axis regulation
Arnett, M. G., Muglia, L. M., Laryea, G., & Muglia, L. J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.215 · Cited by 105
Self-citationHypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
Kageyama, K., Iwasaki, Y., & Daimon, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212242 · Cited by 137
“Pituitary Pomc mRNA levels are not attenuated [11,12]; however, ACTH contents are decreased in the AP of Crf KO mice [14], suggesting a role of CRF in Pomc processing.”
BackgroundMakimura, H., Mizuno, T. M., Roberts, J. L., Silverstein, J. H., Beasley, J., & Mobbs, C. V. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1917 · Cited by 115
“Because adrenalectomy in rats (22) and mice (23) leads to elevated expression of POMC mRNA in the anterior pituitary, we determined levels of POMC mRNA from the anterior pituitary of mice in the present study.”
BackgroundPhysiological roles of urocortins, human homologues of fish urotensin I, and their receptors
Suda, T., Kageyama, K., Sakihara, S., & Nigawara, T. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.027 · Cited by 115
Self-citationMenkes Protein Contributes to the Function of Peptidylglycine α-Amidating Monooxygenase
Steveson, T. C., Ciccotosto, G. D., Ma, X., Mueller, G. P., Mains, R. E., & Eipper, B. A. (2002) · Endocrinology · doi:10.1210/en.2002-220716 · Cited by 94
“Alternatively, the presence of a negative feedback loop monitoring copper availability could result in an elevation in levels of ATP7A, as seen with POMC expression after adrenal failure (88).”
BackgroundCorticotropin-releasing hormone physiology
Majzoub, J. A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02247 · Cited by 91
Self-citationVenihaki, M., Carrigan, A., Dikkes, P., & Majzoub, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7336 · Cited by 89
Self-citationKarpac, J., Ostwald, D., Bui, S., Hunnewell, P., Shankar, M., & Hochgeschwender, U. (2005) · Endocrinology · doi:10.1210/en.2004-1290 · Cited by 74
“In mice, adrenalectomy without adrenal transplants or corticosterone replacement leads to a 10- to 20-fold increase (1–2 ng/ml) over basal levels in serum ACTH 3 h after adrenalectomy (49); elevated levels can still be measured 1 wk after adrenalectomy (46, 50), but ACTH levels have returned to basal levels without co…”
G-protein-coupled glucocorticoid receptors on the pituitary cell membrane
Maier, C., Rünzler, D., Schindelar, J., Grabner, G., Waldhäusl, W., Köhler, G., & Luger, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02462 · Cited by 68
“inhibit ACTH synthesis (Muglia et al., 2000) and release (Hinz”
BackgroundPeeters, B., Meersseman, P., Vander Perre, S., Wouters, P. J., Debaveye, Y., Langouche, L., & Van den Berghe, G. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5427-y · Cited by 48
The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function
Tsatsanis, C., Dermitzaki, E., Venihaki, M., Chatzaki, Ε., MINAS, V., Gravanis, A., & Margioris, A. N. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6555-7 · Cited by 75
Laryea, G., Arnett, M. G., & Muglia, L. J. (2012) · Behavioral Sciences · doi:10.3390/bs2020135 · Cited by 57
“As such, AVP has been shown to compensate for loss of basal, but not stress-activated, CRH-induced secretion of ACTH in CRH KO [5] and CRH-R1 KO mice [6,7].”
BackgroundSelf-citationPituitary-Adrenal Axis Regulation in Crh-Deficient Mice
Muglia, L. J., Bethin, K. E., Jacobson, L., Vogt, S. K., & Majzoub, J. A. (2000) · Endocrine Research · doi:10.3109/07435800009048638 · Cited by 56
Self-citationKhan, A. M., Ponzio, T. A., Sanchez-Watts, G., Stanley, B. G., Hatton, G. I., & Watts, A. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0873-07.2007 · Cited by 55
“Identifying these linkages is critical for understanding principles of signal specificity; perturbing these linkages may complicate obesity, diabetes, and/or stress-related disorders (Muglia et al., 2000; Inouye et al., 2002; Müller et al. 2003; Balthasar et al., 2005).”
Brewer, J. A., Sleckman, B. P., Swat, W., & Muglia, L. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1309 · Cited by 55
“Conversely, removal of all systemic GCs by adrenalectomy, or only the daily circadian elevation of these steroids by genetic means, results in increased thymus size and cellularity (1, 2).”
BackgroundSelf-citationKvetnansky, R., Kubovcakova, L., Tillinger, A., Micutkova, L., Krizanova, O., & Sabban, E. L. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9063-7 · Cited by 53
“It is known that CRH contributes to the regulation of the catecholaminergic system under stressful conditions through the HPA axis (Jeong et al., 2000; Muglia et al., 2000; Venihaki and Majzoub, 2002).”
BackgroundInfluentialZelena, D., Földes, A., Mergl, Z., Barna, I., Kovács, K., & Makara, G. B. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.04.007 · Cited by 55
The physiology of corticotropin-releasing hormone deficiency in mice
Muglia, L. J., Jacobson, L., Weninger, S. C., Karalis, K. P., Jeong, K., & Majzoub, J. A. (2001) · Peptides · doi:10.1016/s0196-9781(01)00385-0 · Cited by 59
Self-citationTargeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior
Contarino, A., & Gold, L. H. (2002) · Neuropeptides · doi:10.1054/npep.2002.0899 · Cited by 46
Stewart, L. Q., Roper, J. A., Young, W. S., O’Carroll, A., & Lolait, S. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.009 · Cited by 45
“In contrast to the rat, there is no clear distinction between the magnocellular- and parvocellulartype Avp- or Oxt-expressing neurones in the PVN in the mouse (e.g., Whitnall, 1993; Muglia et al., 2000 and our unpublished observations).”
Neuropeptides in Anxiety Modulation
Landgraf, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_12 · Cited by 49
GDF15 links adipose tissue lipolysis with anxiety
Townsend, L. K., Wang, D., Knuth, C. M., Fayyazi, R., Mohammad, A., Becker, L. J., Tsakiridis, E. E., Desjardins, E. M., Patel, Z., Valvano, C. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01264-3 · Cited by 50
Zelena, D., Filaretova, L., Mergl, Z., Barna, I., Tóth, Z. E., & Makara, G. B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00118.2005 · Cited by 36
Lessons from CRH knockout mice
Venihaki, M., & Majzoub, J. A. (2002) · Neuropeptides · doi:10.1054/npep.2002.0906 · Cited by 36
Self-citationFayad, R., Sennello, J. A., Kim, S., Pini, M., Dinarello, C. A., & Fantuzzi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200526062 · Cited by 32
Klose, M., Jørgensen, K., & Kristensen, L. Ø. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02111.x · Cited by 29
Gz proteins are functionally coupled to dopamine D2-like receptors in vivo
Leck, K. J., Blaha, C. D., Matthaei, K. I., Forster, G. L., Holgate, J. Y., & Hendry, I. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.05.002 · Cited by 33
“Intraperitoneal administration of 10 mg/kg CRH produced a significant rise in plasma ACTH (F(1,28)¼ 12.5, p 0.01), as previously described (Muglia et al., 2000).”
MethodInfluentialSeasholtz, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10002 · Cited by 27
“Now, Muglia and colleagues have used this interesting mouse model to address the individual roles of glucocorticoids and/or CRH in POMC synthesis and ACTH release (3).”
BackgroundInfluentialKier, A., Han, J., & Jacobson, L. (2004) · Endocrinology · doi:10.1210/en.2004-0650 · Cited by 28
“Higher Cort replacements that would progressively occupy GR suppress ACTH and induce atrophy of the thymus, a typical GR target tissue (29, 34, 46).”
BackgroundMethodInfluentialSelf-citationMukherjee, K., Knisely, A. J., & Jacobson, L. (2004) · Endocrinology · doi:10.1210/en.2004-0147 · Cited by 28
Self-citationLu, Y., Shi, C., Jin, X., He, J., & Yin, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.923475 · Cited by 33
Hu, P., Wang, Y., Qi, X.-H., Shan, Q., Huang, Z., Chen, P., Ma, X., Yang, Y., Swaab, D. F., Samuels, B. A., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02144-6 · Cited by 28
Květňanský, R., Mičutková, L., Kubovčáková, L., Sabban, E. L., Palkovits, M., & Križanová, O. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.050 · Cited by 25
Jacobson, L., Ansari, T., Potts, J. E., & McGuinness, O. P. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00526.2005 · Cited by 24
“The primary metabolic phenotype of the CRH KO mouse is consistent with glucocorticoid deficiency (25, 26, 35).”
BackgroundSelf-citationSmart, J. L., Tolle, V., Otero-Corchón, V., & Low, M. J. (2006) · Endocrinology · doi:10.1210/en.2006-0990 · Cited by 29
“Previous studies examining the correlation of pituitary POMC mRNA levels and circulating ACTH in Crh KO mice have shown discrepancies between the two measures, which suggest independent actions of CRH receptor stimulation and glucocorticoid receptor inhibition on Pomc gene expression and ACTH secretion (49, 50).”
BackgroundZelena, D., Pintér, O., Balázsfi, D., Langnaese, K., Richter, K., Landgraf, R., Makara, G. B., & Engelmann, M. (2015) · Amino Acids · doi:10.1007/s00726-015-2026-x · Cited by 25
“Further, at rest higher AVP mRNA was detected in CRH knockout mice (Muglia et al. 2000).”
BackgroundMiller-Scandle, T., & McGee, D. W. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01352.x · Cited by 22
Kageyama, K., & Suda, T. (2008) · Peptides · doi:10.1016/j.peptides.2008.12.007 · Cited by 27
Self-citationCatecholamine Synthesizing Enzymes and Their Modulation by Immobilization Stress in Knockout Mice
Kubovčáková, L., Tybitanclová, K., Sabban, E. L., Majzoub, J. A., Zórad, Š., Vietor, I., Wagner, E. F., Križanová, O., & Květňanský, R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.056 · Cited by 22
Self-citationKubovčáková, L., Mičutková, L., Bartošová, Z., Sabban, E. L., Križanová, O., & Květňanský, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03832.x · Cited by 21
“CRH KO mice exhibit very low glucocorticoid levels and elevated hypothalamic vasopressin mRNA (Muglia et al. 2000).”
BackgroundResultInfluentialJeong, K., Sakihara, S., Widmaier, E. P., & Majzoub, J. A. (2004) · Endocrinology · doi:10.1210/en.2003-1558 · Cited by 22
Self-citationInvolvement of upstream open reading frames in regulation of rat V1bvasopressin receptor expression
Nomura, A., Iwasaki, Y., Saito, M., Aoki, Y., Yamamori, E., Ozaki, N., Tachikawa, K., Mutsuga, N., Morishita, M., Yoshida, M., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e780 · Cited by 21
“It has also been shown that both hormones are involved in the synthesis and secretion of ACTH through specific receptors (17).”
BackgroundGene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 25
“…accounts for a high percentage of immunoreactive ACTH in the anterior pituitary in CRH KO mice, probably because CRH serves as an activator of processing enzymes such as prohormone convertase 1/3 (PC1/3) which produces the authentic-sized, bioactive ACTH (Muglia et al. 2000; Fukuda et al. 2004).”
The central CLOCK system and the stress axis in health and disease
Kassi, E. N., & Chrousos, G. P. (2013) · HORMONES · doi:10.14310/horm.2002.1402 · Cited by 27
“In CRH-deficient (knockout) mice, adrenalectomy increases POMC gene expression in the pituitary, but not ACTH secretion unless CRH is replaced.(199) Glucocorticoids suppress SR-BI”
BackgroundKvětňanský, R., Križanová, O., Tillinger, A., Sabban, E. L., THOMAS, S. A., & Kubovčáková, L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.033 · Cited by 18
Stewart, L. Q., Hindmarch, C. C. T., Qiu, J., Tung, Y. C. L., Yeo, G. S. H., & Murphy, D. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02093.x · Cited by 21
Tillinger, A., Nostramo, R., Květňanský, R., Serova, L. I., & Sabban, E. L. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12152 · Cited by 17
Fukuda, Y., Kageyama, K., Nigawara, T., Kasagi, Y., & Suda, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.006 · Cited by 15
Self-citationKageyama, K., Tamasawa, N., & Suda, T. (2011) · Stress · doi:10.3109/10253890.2010.536279 · Cited by 17
“1995, 1997), but ACTH content is decreased in the AP of CRF KO (Muglia et al. 2000), suggesting the involvement of CRF in stimulating the processing of POMC.”
BackgroundSelf-citationNg, P. C., Lam, C. W. K., Lee, C., Chan, I. H. S., Wong, S. P. S., & Fok, T. F. (2008) · Neonatology · doi:10.1159/000143396 · Cited by 14
“our results demonstrated that in preterm infants the suppression of pituitary corticotrophs was not the rate-limiting step for recovery after high-dose dexamethasone treatment. Further, it would appear that pituitary corticotrophs were probably more resilient to exogenous glucocorticoid suppression, as the recovery ph…”
ResultAdrenocorticotropic hormone protects learning and memory function in epileptic Kcna1 -null mice
Scantlebury, M. H., Chun, K., Ma, S., Rho, J. M., & Kim, D. Y. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.069 · Cited by 14
60 YEARS OF POMC: N-terminal POMC peptides and adrenal growth
Bicknell, A. B. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0269 · Cited by 13
Nostramo, R., Tillinger, A., Saavedra, J. M., Kumar, A., Pandey, V. G., Serova, L. I., Květňanský, R., & Sabban, E. L. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0181 · Cited by 12
Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function
Yamamoto, M., Ben-Shlomo, A., Kameda, H., Fukuoka, H., Deng, N., Ding, Y., & Melmed, S. K. (2018) · JCI Insight · doi:10.1172/jci.insight.122932 · Cited by 10
Pomc Knockout Mice Have Secondary Hyperaldosteronism Despite an Absence of Adrenocorticotropin
Linhart, K. B., & Majzoub, J. A. (2007) · Endocrinology · doi:10.1210/en.2006-1136 · Cited by 10
“To stimulate adrenal aldosterone secretion, mice were injected ip with either 10 g/kg body weight of synthetic ACTH (Cortrosyn; Amphastar Pharmaceuticals, Rancho Cucamonga, CA) alone (16, 20), 50 g/kg body weight of human angiotensin II (Ciba, Basel, Switzerland) alone, or with a combination of the same concentrations…”
MethodSelf-citationSoto-Rivera, C. L., & Majzoub, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00003-9 · Cited by 15
Self-citationRegulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary
Kageyama, K., Sakihara, S., & Suda, T. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.10.003 · Cited by 10
Self-citationMifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency
Cohan, P. (2016) · Case Reports in Endocrinology · doi:10.1155/2016/4709597 · Cited by 8
Jacobson, L., & Pacák, K. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.013 · Cited by 7
“In keeping with their glucocorticoid deficiency, CRH KO mice exhibit characteristics of increased insulin sensitivity, including lower levels of plasma insulin and body fat [12,13].”
BackgroundMethodSelf-citationWang, O., & Majzoub, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10003-3 · Cited by 7
Self-citationMolecular biology of the HPA axis
Abel, K.-B., & Majzoub, J. A. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80008-2 · Cited by 11
Self-citationRegulation and Actions of Corticotropin‐Releasing Hormone
Weninger, S. C., & Majzoub, J. A. (2001) · Wiley eBooks · doi:10.1002/cphy.cp070406 · Cited by 5
Self-citationBedeutung der Hypothalamus-Hypophysen-Nebennierenrinden-Achse
Bullmann, C. (2020) · Gynäkologische Endokrinologie · doi:10.1007/s10304-020-00324-z · Cited by 3
Onose, H., TAMURA, Y., Fujita, H. M., Nakano, T., & Shibasaki, T. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.415 · Cited by 2
“Furthermore, it is reported that CRH knockout (KO) mice demonstrated impaired adrenocortical function, although the basal plasma ACTH of CRH KO mice was similar to that of wild type mice [19].”
ResultGaston, L. S., Jorgensen, B., Friedman, H., Sherman, M. S., & Majzoub, J. A. (2026) · Endocrinology · doi:10.1210/endocr/bqag081
Self-citationGaston, L. S., & Majzoub, J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00013-5 · Cited by 1
Self-citationMultifactorial regulation of the corticotroph axis: animal models
Karalis, K. P. (2003) · Endocrine updates · doi:10.1007/978-1-4615-0501-3_3
“Secretion of ACTH is normalized in adrenalectomized Crh-/- mice only following correction of their primary genetic defect by continuous CRH infusion ( 4 ).”
BackgroundJacobson, L., Ansari, T., Potts, J., & McGuinness, O. P. (2016)
Self-citationPROTECTIVE EFFECT OF CYSTAMINE ON THE INDUCTION CAPACITY OF THE IRRADIATED EYE.
Popov, D. (1969) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Regulation and Actions of Corticotropin‐Releasing Hormone
Weninger, S. C., & Majzoub, J. A. (2000) · Comprehensive physiology · doi:10.1002/j.2040-4603.2000.tb01511.x
“Furthermore, CRH-deficient mice have a normal rise in blood corti-cotropin following an infusion of CRH (133a).”
Self-citationStojiljković, A., Čupić, Ž., Maćešić, S. R., Ivanović-Šašić, A., & Mojović, M. (2025) · Royal Society Open Science · doi:10.1098/rsos.251323
Models of depression for preclinical drug discovery and development: an update of the literature
Pavlidi, P., Kalampokis, D., Ioannidi, I., Skourti, K., Sotiropoulos, I., Antoniou, K., Dalla, C., & Kokras, N. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2716135
“Similarly, life-long CRH overexpression more closely models developmental stress programming, whereas germline CRH deletion allows compensatory adaptations that may obscure acute CRH-dependent effects possibly involved in human depression, which is episodic in its natural course [249,250].”
Metadata
- Authors
- Muglia, L. J., Jacobson, L., Luedke, C., Vogt, S. K., Schaefer, M. L., Dikkes, P., Fukuda, S., Sakai, Y., Suda, T., & Majzoub, J. A.
- Affiliations
- Washington University in St. Louis (US)
- Boston Children's Hospital (US)
- Hirosaki University (JP)
- Albany Medical College (US)
- Corresponding author
- Majzoub, Joseph A.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-05-01
- Volume
- 105
- Issue
- 9
- Pages
- 1269-1277
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC315436
- OpenAlex
- W2153745738
- Cited by
- 80
- References
- 41
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 2 · 2013: 2 · 2012: 2
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- corticotropin-releasing factor, ACTH, adrenal insufficiency, hypothalamic-pituitary-adrenal axis, glucocorticoid feedback, adrenalectomy, ACTH secretion, glucocorticoid replacement therapy
- MeSH terms
- Adrenal Insufficiency, Adrenalectomy, Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Female, Glucocorticoids, Hypothalamo-Hypophyseal System, Male, Pituitary Gland, Pituitary-Adrenal System, Pro-Opiomelanocortin, Vasopressins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.